Procyon Valuation Multiples

Procyon is valued at $1M as of November 2026, a 0.3x revenue multiple. In the last fiscal year, Procyon revenue was $5M and Procyon EBITDA was $75K.

Procyon Overview

About Procyon

Procyon Corp is a United-based company, through its subsidiary, it is engaged in developing and marketing proprietary medical products used to treat pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems. Its wound care products are sold through distributors to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, and physicians and other healthcare practitioners. The firm's product lines are AMERX, AMERIGEL, and HELIX3 Bioactive Collagen. The skin and wound care products are marketed under the trademark AMERIGEL which contains the proprietary ingredient OAKIN which promotes wound healing and healthy skin. The corporation markets its products in the United States.


Founded

1987

HQ

United States

Employees

25

Financials (Last FY)

Revenue: $5M
EBITDA: $75K

EV

$1M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Procyon Financials

Procyon reported last fiscal year revenue of $5M and EBITDA of $75K.

In the same fiscal year, Procyon generated $4M in gross profit, $75K in EBITDA, and had net loss of ($341K).


Procyon P&L

In the most recent fiscal year, Procyon reported revenue of $5M and EBITDA of $75K.

Procyon is unprofitable as of last fiscal year, with gross margin of 78%, EBITDA margin of 2%, and net margin of (7%).

See analyst estimates for Procyon
Last FY202620272028
Revenue$5M
Gross Profit$4M
Gross Margin78%
EBITDA$75K
EBITDA Margin2%
EBIT Margin(5%)
Net Profit($341K)
Net Margin(7%)
Net Debt($6K)

Financial data powered by Morningstar, Inc.

Procyon Stock Performance

Procyon has current market cap of $1M, and enterprise value of $1M.

Market Cap Evolution


Procyon's stock price is $0.18.

Procyon has an EPS (earnings per share) of $-0.04.

See more trading valuation data for Procyon
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1M$1M0.0%0.0%--$-0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Procyon Valuation Multiples

Procyon trades at 0.3x EV/Revenue multiple, and 19.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Procyon

Procyon Financial Valuation Multiples

As of November 6, 2026, Procyon has market cap of $1M and EV of $1M.

Procyon has a P/E ratio of (4.3x).

Last FY202620272028
EV/Revenue0.3x
EV/EBITDA19.6x
EV/EBIT(6.3x)
EV/Gross Profit0.4x
P/E(4.3x)
EV/FCF(11.7x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Procyon Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Procyon Margins & Growth Rates

In the most recent fiscal year, Procyon reported gross margin of 78%, EBITDA margin of 2%, and net margin of (7%).

See estimated margins and future growth rates for Procyon

Procyon Margins

Last FY202720282029
Gross Margin78%
EBITDA Margin2%
EBIT Margin(5%)
Net Margin(7%)
FCF Margin(3%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Procyon Operational KPIs

Procyon's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.

Access forward-looking KPIs for Procyon
Last FY202620272028
Revenue per Employee$0.2M
Opex per Employee$0.2M
G&A Expenses to Revenue41%
Opex to Revenue83%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Procyon Competitors

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E

This data is available for Pro users. Sign up to see all Procyon competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Procyon

When was Procyon founded?Procyon was founded in 1987.
Where is Procyon headquartered?Procyon is headquartered in United States.
How many employees does Procyon have?As of today, Procyon has over 25 employees.
Is Procyon publicly listed?Yes, Procyon is a public company listed on OTCM.
What is the stock symbol of Procyon?Procyon trades under PCYN ticker.
Who are competitors of Procyon?Procyon main competitors include
What is the current market cap of Procyon?Procyon's current market cap is $1M.
What is the current revenue of Procyon?Procyon's last fiscal year revenue is $5M.
What is the current EV/Revenue multiple of Procyon?Current revenue multiple of Procyon is 0.3x.
Is Procyon profitable?No, Procyon is not profitable.
How many companies Procyon has acquired to date?Procyon hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Procyon has invested to date?Procyon hasn't invested in any companies yet (or none have been disclosed publicly).

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial